IBM became the first major company to pledge it would not to use genetic data to determine healthcare or benefits. The news is significant because IBM is putting a stake in the ground in an area of healthcare law that is poised to become hotly debated. The move was praised by Genetic Alliance, a Washington-based patients advocacy group. Interestingly, Big Blue develops software and services for all kinds of genetics-related research and testing.Article (subscription required).